Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

Numinus Wellness Inc. (TSX: NUMI | OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022, at 2:30 p.m. ET / 11:30 a.m. PT.

The discussion will focus on Numinus’ recently completed and transformative acquisition of Novamind; the value this acquisition brings to the Company; and key growth opportunities and catalysts for Numinus.

For all investors and other persons interested in participating, please register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus’ management, please send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.